News Digest / Ticker: MNKD

Ticker: MNKD

09:19am, Monday, Jan 26, 2026

MannKind Shares Climb Following FDA's Revised Afrezza Insulin Label

MannKind Corporation (NASDAQ:MNKD) stock jumped 3.5% on news that the FDA updated Afrezza's prescribing info, simplifying dosing guidance for patients switching from injectable mealtime insulin to inhaled therapy.

08:10am, Wednesday, Aug 06, 2025

MannKind Reports Mixed Q2 2025 Earnings with Revenue Growth Amid Rising Expenses and Collaborative Challenges

09:06am, Thursday, May 08, 2025

MannKind Reports Q1 2025: Revenue Up 18%, But Rising Costs and Currency Losses Raise Caution